Litcius/Paper detail

Budesonide Orodispersible Tablets Maintain Remission in a Randomized, Placebo-Controlled Trial of Patients With Eosinophilic Esophagitis

Alex Straumann, Alfredo J. Lucendo, Stephan Miehlke, Michael Vieth, Christoph Schlag, Luc Biedermann, Cecilio Santander Vaquero, Constanza Ciriza de los Ríos, Christoph Schmoecker, Ahmed Madisch, Petr Hrúz, Jamal Hayat, Ulrike von Arnim, Albert J. Bredenoord, Stefan Schubert, Ralph Müeller, Roland Greinwald, Alain Schoepfer, Stephen Attwood, Jan Tack, Stephan Miehlke, Monther Bajbouj, Stefan Brückner, Christiane Fibbe, Sebastian Haag, Christoph Schmöcker, Dirk Hartmann, Frank Lammert, Ahmed Madisch, Max Reinshagen, Stefan Schubert, Ulrike von Arnim, Norbert Börner, Dieter Witzemann, Karel Caca, Jörg Albert, Stefan Zeuzem, Felix Wiedbrauck, Helmut Messmann, Albert J. Bredenoord, Robert C. Verdonk, Franciscus Wolfhagen, Alfredo Lucendo Villarin, Cecilio Santander Vaquero, Constanza Ciriza de los Ríos, Antonia Perelló Juan, Isabel Pérez‐Martínez, Joaquín Rodríguez Sánchez-Migallón, Jésus Barrio, ÁngelesPérez Aisa, Alex Straumann, Petr Hrúz, Alain Schoepfer, Luc Biedermann, Jamal Hayat, Anjan Dhar

2020Gastroenterology206 citationsDOIOpen Access PDF

Topics & Concepts

Eosinophilic esophagitisBudesonideMedicinePlaceboGastroenterologyInternal medicineRandomized controlled trialEsophagitisAsthmaPathologyDiseaseAlternative medicineRefluxEosinophilic EsophagitisFood Allergy and Anaphylaxis ResearchEosinophilic Disorders and Syndromes
Budesonide Orodispersible Tablets Maintain Remission in a Randomized, Placebo-Controlled Trial of Patients With Eosinophilic Esophagitis | Litcius